Glyco P 0.2 Injection is used to reduce excessive salivary, throat, and airway secretions before and during surgical procedures, and to prevent a slow heart rate (bradycardia) caused by vagal reflexes during surgery. It also serves as an adjunct in peptic ulcer disease and to reverse certain effects of medicines used to reverse neuromuscular blockade.
It contains glycopyrrolate, an anticholinergic agent that does not cross into the brain, so it provides its effects without causing confusion or agitation. It is given intravenously or intramuscularly by healthcare professionals in a clinical setting.
This medicine is used entirely within the hospital or clinical setting under medical supervision, with monitoring of heart rate, secretions, and bladder function as clinically appropriate.
Before administration, the care team reviews for any glaucoma, enlarged prostate, severe heart disease, or other medicines. Urinary retention and dry mouth are expected effects and are monitored by the clinical team.





























